MATINAS BIOPHARMA HOLDINGS, INC. Notes Payable, Current
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Notes Payable, Current of $79.94 thousand as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2020-03-09
- 2019-03-31: Notes Payable, Current $79.94K.
- 2018-12-31: Notes Payable, Current $199.84K.
- 2018-09-30: Notes Payable, Current $319.75K.
- 2018-03-31: Notes Payable, Current $42.56K.
| Period end | Notes Payable, Current |
|---|---|
| 2019-03-31 | $79.94K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $199.84K 10-K · filed 2020-03-09 |
| 2018-09-30 | $319.75K 10-Q · filed 2018-11-09 |
| 2018-03-31 | $42.56K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $170.24K 10-K · filed 2019-04-01 |
| 2017-09-30 | $297.91K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-08 |
| 2017-03-31 | $47.22K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $118.05K 10-K · filed 2018-03-16 |
| 2016-09-30 | $188.87K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-31 |
| 2015-09-30 | $10.00K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $10.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $10.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $0.00 10-Q · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |